Why You Should Retain IQVIA Holdings Stock in Your Portfolio Now

Zacks2024-11-29

While IQVIA Holdings Inc. IQV benefits from its market leadership, data-driven innovation, and global expansion, it must navigate pricing pressure. IQV has an expected long-term (three to five years) ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2487344725?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OsqSjFs1.NamtGUQHLt17g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/28cf39ef4d25f17fc9366f3b59dc6140","is_english":true,"pubTime":"2024-11-29 01:05","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2487344725","market":"us","top_or_hot":-1,"title":"Why You Should Retain IQVIA Holdings Stock in Your Portfolio Now","media":"Zacks","content":"<div>\n<p>While IQVIA Holdings Inc. IQV benefits from its market leadership, data-driven innovation, and global expansion, it must navigate pricing pressure.\nIQV has an expected long-term (three to five years) ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-retain-iqvia-holdings-stock-170500059.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why You Should Retain IQVIA Holdings Stock in Your Portfolio Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy You Should Retain IQVIA Holdings Stock in Your Portfolio Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-29 01:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-retain-iqvia-holdings-stock-170500059.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While IQVIA Holdings Inc. IQV benefits from its market leadership, data-driven innovation, and global expansion, it must navigate pricing pressure.\nIQV has an expected long-term (three to five years) ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-retain-iqvia-holdings-stock-170500059.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0130518102.USD","symbol_name":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","start_time":0,"source_url":"https://finance.yahoo.com/news/why-retain-iqvia-holdings-stock-170500059.html","article_id":"2487344725","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OsqSjFs1.NamtGUQHLt17g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/28cf39ef4d25f17fc9366f3b59dc6140"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2487344725","pubTimestamp":1732813500,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"While IQVIA Holdings Inc. IQV benefits from its market leadership, data-driven innovation, and global expansion, it must navigate pricing pressure.IQV has an expected long-term  EPS growth rate of 9.6%. The company’s earnings for 2024 and 2025 are expected to grow 9% and 6.9%, respectively.IQV’s Global Reach, Market Leadership in Healthcare Analytics. IQVIA operates in over 100 countries, giving it a vast global footprint. This extensive presence enables it to tap into emerging markets with growing healthcare needs and opportunities for clinical research. Its international reach allows revenue growth beyond developed markets, where drug approvals and research demand remain high.IQVIA is a leading global provider of advanced analytics, technology solutions and contract research services in the healthcare sector. Its comprehensive offering of clinical development, data analytics, and commercialization services makes it indispensable to pharmaceutical companies, biotechnology firms and me","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","BK4187":"航天航空与国防","QFIN":"奇富科技","BK4531":"中概回港概念","BK4523":"印度概念","BK4585":"ETF&股票定投概念","LU2778985437.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"A\" (USD) INC","LU1981816686.USD":"EASTSPRING INV ASIAN MULTI FACTOR EQUITY \"A\" (USD) ACC","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0882574055.USD":"富达全球健康医疗A ACC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","BK4121":"生命科学工具和服务","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","BK4166":"消费信贷","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","BK4588":"碎股","BK4526":"热门中概股","BK4123":"调查和咨询服务","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","BK4503":"景林资产持仓","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","TTM":"塔塔汽车","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","IQV":"艾昆纬","LU0528227936.USD":"富达环球人口趋势基金A-ACC","PSN":"Parsons Corp","LU2476274308.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (USD) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","BK4099":"汽车制造商","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU0566484027.USD":"安本美国小盘成长股","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","BK4530":"医药外包概念","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU1261432733.SGD":"Fidelity World A-ACC-SGD"},"translate_title":"为什么您现在应该在您的投资组合中保留IQVIA Holdings股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TTM":1,"QFIN":1,"PSN":1,"IQV":1},"content_text":"While IQVIA Holdings Inc. IQV benefits from its market leadership, data-driven innovation, and global expansion, it must navigate pricing pressure.\nIQV has an expected long-term (three to five years) EPS growth rate of 9.6%. The company’s earnings for 2024 and 2025 are expected to grow 9% and 6.9%, respectively.\nIQV’s Global Reach, Market Leadership in Healthcare Analytics\nIQVIA operates in over 100 countries, giving it a vast global footprint. This extensive presence enables it to tap into emerging markets with growing healthcare needs and opportunities for clinical research. Its international reach allows revenue growth beyond developed markets, where drug approvals and research demand remain high.\nIQVIA is a leading global provider of advanced analytics, technology solutions and contract research services in the healthcare sector. Its comprehensive offering of clinical development, data analytics, and commercialization services makes it indispensable to pharmaceutical companies, biotechnology firms and medical device manufacturers. This strong market position allows IQVIA to maintain stable revenue streams and build long-term client relationships.\n\nIQVIA Holdings Inc. Revenue (TTM)\n  \nIQVIA Holdings Inc. revenue-ttm | IQVIA Holdings Inc. Quote\n\nIQVIA is known for its innovative use of technology and data analytics, particularly through its proprietary \"IQVIA CORE\" platform, which integrates data, advanced analytics and expert services. This platform allows healthcare organizations to accelerate drug development, optimize clinical trials and streamline commercial strategies. The company’s data-driven approach enhances its competitiveness and makes it a go-to partner for healthcare clients seeking to leverage big data.\nSome Risks\nLarge pharmaceutical companies continue to apply pricing pressure on IQVIA’s operations. These clients, adopting a more cautious approach to their budgets, are increasingly engaged in difficult price negotiations. This budgetary conservatism is driven by various factors, including broader economic uncertainties and the need to optimize spending. As a result, IQVIA faces the challenge of balancing competitive pricing with steady profitability, as clients demand more cost-effective solutions without compromising the quality of services provided.\nThe company currently has no plan to pay cash dividends on common stock. Future dividend payments depend on factors such as financial condition, cash requirements and contractual restrictions. Investors seeking cash dividends should avoid buying IQVIA.\nZacks Rank and Stocks to Consider\nIQV currently carries a Zacks Rank #3 (Hold).\nSome other top-ranked stocks in the broader Zacks Business Services sector are Parsons PSN and Qifu Technology QFIN.\nParsons sports a Zacks Rank of 1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.\nPSN has a long-term earnings growth expectation of 18.6%. It delivered a trailing four-quarter earnings surprise of 17.5%, on average.\nQifu Technology sports a Zacks Rank of 1 at present. It has a long-term earnings growth expectation of 20.9%.\nQFIN delivered a trailing four-quarter earnings surprise of 12.4%, on average.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nIQVIA Holdings Inc. (IQV) : Free Stock Analysis Report\nQifu Technology, Inc. (QFIN) : Free Stock Analysis Report\nParsons Corporation (PSN) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2487344725"}